Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.000
-0.330 (-7.62%)
At close: Apr 21, 2026, 4:00 PM EDT
3.900
-0.100 (-2.50%)
After-hours: Apr 21, 2026, 7:20 PM EDT
Biodexa Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
2.59M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 381.00K | -318.00K | -45.49% |
| Dec 31, 2022 | 699.00K | 121.00K | 20.93% |
| Dec 31, 2021 | 578.00K | 235.00K | 68.51% |
| Dec 31, 2020 | 343.00K | -331.00K | -49.11% |
| Dec 31, 2019 | 674.00K | -1.26M | -65.22% |
| Dec 31, 2018 | 1.94M | 949.00K | 95.96% |
| Dec 31, 2017 | 989.00K | -334.00K | -25.25% |
| Dec 31, 2016 | 1.32M | -52.00K | -3.78% |
| Dec 31, 2015 | 1.38M | 1.22M | 775.80% |
| Dec 31, 2014 | 157.00K | 10.00K | 6.80% |
| Dec 31, 2013 | 147.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBDRX News
- 19 days ago - Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies - GlobeNewsWire
- 25 days ago - Preliminary Results for the Year Ended 31 December 2025 - GlobeNewsWire
- 4 weeks ago - Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group - GlobeNewsWire
- 4 weeks ago - ADR Ratio Change - GlobeNewsWire
- 6 weeks ago - Biodexa Announces Support for Life's a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients - GlobeNewsWire
- 2 months ago - Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer - Accesswire
- 2 months ago - Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST - GlobeNewsWire
- 3 months ago - Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary - GlobeNewsWire